Olympus Corp SP ADR (OCPNY) 32.4600 $OCPNY
Correction: Hospital Superbug Outbreak story
By BRIAN MELLEY - AP - Fri Aug 26, 6:40PM CDT
LOS ANGELES (AP) — In a Feb. 20, 2015 story about an antibiotic-resistant "superbug" outbreak at Ronald Reagan UCLA Medical Center, The Associated Press mischaracterized a statement an expert made about proving the cause of an infection. Lawrence Muscarella, a health care and sterilization expert, said he was suggesting an argument hospitals might use when he said, "Proving causation is impossible." Muscarella said an infection can be proven to come from a hospital instrument.
Zacks.com featured highlights: Apogee Enterprises, AMN Healthcare Services, Gibraltar Industries, Liberty Interactive Group and Olympus
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:30AM CDT
Zacks.com featured highlights: Apogee Enterprises, AMN Healthcare Services, Gibraltar Industries, Liberty Interactive Group and Olympus
APOG: 49.02 (+1.05), AHS: 35.85 (+0.08), ROCK: 39.11 (+0.86), QVCA: 21.17 (+0.08)
Look Beyond Earnings: 5 Stocks with Increasing Cash Flows
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:11AM CDT
For any prudent investment, look at a company's ability to produce cash, the lifeblood of business, the fuel for growth and a cushion to downturn.
APOG: 49.02 (+1.05), AHS: 35.85 (+0.08), ROCK: 39.11 (+0.86), QVCA: 21.17 (+0.08)
VIDA and Olympus Expand Strategic Partnership
PR Newswire - Mon May 16, 12:50PM CDT
VIDA Diagnostics, Inc. ("VIDA"
, the leader in precision pulmonary imaging, announced an expanded collaboration with Olympus Respiratory America, a leading developer of devices for the treatment of acute and chronic conditions of the lung and a subsidiary of Olympus Corporation, at the 2016 American Thoracic Society Meeting. Under the agreement, VIDA and Olympus will incorporate precision informatics into current and future diagnostic and therapeutic procedural workflows to manage patients with pulmonary diseases.
Olympus Corporation of the Americas Enters Into US And Canada Distribution Agreement With Arc Medical Design Ltd, A Subsidiary Of Norgine For ENDOCUFF VISION®
PR Newswire - Fri May 06, 7:00AM CDT
Olympus Corporation of the Americas today announced a new distribution agreement with Norgine B.V. and its subsidiary Arc Medical Design Ltd. by which Olympus Corporation of the Americas becomes the exclusive distributor of ENDOCUFF VISION® in the U.S. and Canada. The ENDOCUFF VISION® will be showcased at the adjoining Arc and Olympus booths at the Digestive Disease Week (DDW) conference in San Diego, Calif. May 22-26, 2016.
Mitsubishi Motors says false mileage tests done since 1991
By YURI KAGEYAMA - AP - Tue Apr 26, 6:30PM CDT
TOKYO (AP) — Mitsubishi Motors Corp., the Japanese automaker that acknowledged last week that it had intentionally lied about fuel economy data for some models, said an internal investigation found such tampering dated to 1991.
Olympus Corporation Promotes Donna Miller to Head of HQ Legal/Global General Counsel and Caroline West to Global Chief Compliance Officer
PR Newswire - Mon Apr 25, 8:05AM CDT
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced the appointment of two senior level positions in the company. The promotions represent the continued globalization of the Company and reinforce the Company's commitment to an increasingly proactive approach to rapidly changing international markets. These promotions further underscore the importance of the compliance and legal departments in meeting company objectives.
Digital Pathology Market: Global Industry Analysis 2015-2025 - Key Players are GE Healthcare, Sectra AB & Olympus Corporation - Research and Markets
BusinessWire - Mon Apr 18, 7:36AM CDT
Research and Markets has announced the addition of the "Digital Pathology Market: Global Industry Analysis and Opportunity Assessment, 2015-2025" report to their offering.
Report: More infections from dirty scopes than estimated
By MATTHEW PERRONE - AP - Fri Apr 15, 5:00PM CDT
WASHINGTON (AP) — At least 300 patients have been sickened by life-threatening infections linked to contaminated medical scopes — more than previously estimated by federal regulators, according to figures released Friday.
Global Life Science Microscopy Devices Market Assessments & Forecasts 2015-2019 with Leica Microsystems, Olympus, JEOL, Carl Zeiss, FEI, Meiji Techno & Tescan Orsay
GlobeNewswire - Fri Jan 29, 2:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/55pccb/global_life) has announced the addition of the "Global Life Science Microscopy Devices Market Assessment & Forecast: 2015 - 2019" report to their offering.
Cell Analysis Market Forecast to 2020 - Expected to Reach $26 Billion, Growing at CAGR of 6.56%
M2 - Mon Jan 25, 3:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/mxg28x/cell_analysis) has announced the addition of the "Cell Analysis Market by Product, & Consumables, by Process, & by End User - Forecast to 2020" report to their offering. The global cell analysis market is expected to reach $26.0 billion by 2020 from $19.0 billion in 2015, growing at a CAGR of 6.56% from 2015 to 2020. The instruments segment is expected to register the highest growth rate in the cell analysis market, by product, during the forecast period. Its favorable growth is attributed to biological relevance for new drug discoveries, cancer research, and government funding & support for cell-based research. Furthermore, instruments are rapidly adopted by biotechnology and biopharmaceutical industries for performing cell analysis biotechnology products and biopharmaceuticals. This is another major reason for the growth of this market. Major factors contributing to growth of the cell analysis market include: - Rising incidence of chronic and infectious diseases - Growing healthcare industry and medical spending - Rising incidence of cancer - Introduction of technologically advanced products - Corporate and government funding for cell-based research. The relatively untapped markets of the Asia-Pacific region and the advent of microfluidics in cell analysis have opened an array of opportunities for the cell analysis market. However, reluctance amongst researchers to use advanced cell analysis techniques and high cost of instruments are expected to restrain the growth of this market. Companies Mentioned: - Agilent Technologies, Inc. - Becton, Dickinson and Company - Danaher Corporation - GE Healthcare - Merck KGAA - Olympus Corporation - Perkinelmer, Inc. - Promega Corporation - Tecan Group Ltd. - Thermo Fisher Scientific, Inc. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Global Cell Analysis Market, By Product 7 Global Cell Analysis Market, By Process 8 Global Cell Analysis Market, By End User 9 Global Cell Analysis Market, By Region 10 Competitive Landscape 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/mx...l_analysis
A: 47.62 (+0.30), DHR: 82.13 (+0.29)
Global Life Science Microscopy Devices Market - Expected to Grow to $2,472.2 Million by 2019 at a CAGR of 6.8%
M2 - Fri Jan 22, 3:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/gl3kg6/global_life) has announced the addition of the "Global Life Science Microscopy Devices Market Assessment & Forecast: 2015 - 2019" report to their offering. Pricing remains a major challenge to growth of the market as potential buyers still continue to rely on refurbished sales. Spares and additional parts of several high-resolution microscopes are considerably expensive. Moreover several microscopes use radiation for which shielding is of extreme importance. Thus a large variety of modern microscopy technology continues to be out of reach for most academic and research organizations in emerging countries. In well-funded institutions within emerging countries such as India, Malaysia, Brazil, China students and researchers are required to accommodate with using just one or two systems. Since the average cost of scanning probe and electron microscopes can exceed beyond US$ 500,000 - US$ 2,000,000 the cost accounts for a sizable portion of the total funds allotted. Although economy in these regions is improving, their purchase power is expected to be strong only by the end of the forecast period or may even extend into the next decade. Companies Mentioned: - Accu Scope Inc - Bruker Corporation - Carl Zeiss GmbH - Coxem - Etaluma - Euromex Microscopes - FEI Company - Hitachi Hightech - Horiba Ltd - JEOL Ltd - Meiji Techno - Nikon Corporation - Olympus Corporation - Optika Italy - Park Systems - Renishaw - Rigaku Corporation - Tescan Orsay Holdings - TSI - Variscope Key Topics Covered: Chapter 1 Preface Chapter 2 Market Inferences Chapter 3 Market Dynamics Chapter 4 Life Science Microscopy Devices - By Technology Chapter 5 Life Science Microscopy Devices - By Applications Chapter 6 Life Science Microscopy Devices - By Geography For more information visit http://www.researchandmarkets.com/research/gl...lobal_life
FEIC: 106.52 (-0.16)
Non Destructive Testing (NDT) Market 2015-2020 by Method (UT, RT, LPT, MPT, ECT, VI), End-User (Aerospace & Defense, Power Generation, Infrastructure, Oil & Gas, Automotive), Technique & Application
M2 - Thu Jan 14, 6:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/g3lm6v/non_destructive) has announced the addition of the "Non Destructive Testing (NDT) Market - Global Forecast to 2020" report to their offering. The non-destructive testing market is estimated to be valued at USD 12.98 Billion in 2015 and is projected to reach USD 18.88 Billion by 2020, at a CAGR of 7.78% from 2015 to 2020. This report provides qualitative and quantitative information about the global NDT market. It identifies the market application gaps, emerging technologies, the need for new product launches, and high potential geographic regions and countries. It also provides a segmentation of the market, tracking the market size, market share, revenue projections, and financial portfolio, covering a broad spectrum of the different methods, end-user, applications, and techniques of NDT industry. NDT is considered a basic need in industries such as aerospace, oil & gas, petroleum, and construction, among others. Innovations in the NDT equipment market have increased commercially after the introduction of advanced X-ray equipment such as micro focus X-ray tools, integrated X-ray equipment, glass X-ray tubes with window, radiation shielded X-ray equipment, and so on. Furthermore, the forecast period offers huge growth potential for technologies such as computed tomography, phased array ultrasonic testing, and data management tools as these techniques are more efficient in terms of deriving accurate results. The research methodology used to estimate and forecast the NDT market begins with capturing data on key NDT equipment revenues through secondary research. The NDT service offerings are also taken into consideration to determine the market segmentation. The bottom-up procedure was employed to arrive at the overall market size of the global NDT market from the revenue of the key players in the market. After arriving at the overall market size, the total market was split into several segments and sub-segments which are then verified through primary research by conducting extensive interviews with key people such as CEOs, VPs, Directors and executives. This data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments. The ecosystem of the NDT market comprises oil exploration industry, oil refineries, aerospace industry, construction industry, inspection service providers, and non-destructive testing facilities among other. This report would help the NDT component supplier, NDT service providers, safety and regulatory authorities to identify hot revenue pockets in this market. Scope of the Report This research report categorizes the NDT market into the following segments and sub-segments: Global NDT Market, By Method - Ultrasonic testing - Radiography testing - Liquid Penetrant testing - Magnetic particle testing - Eddy-current testing - Visual inspection Global NDT Market, By End-User - Aerospace & Defense industry - Automotive industry - Oil & gas industry - Infrastructure Industry - Power generation industry Global NDT Market, By Technique - Surface Examination technique - Volumetric Examination Technique - Condition Monitoring technique - Integrity Examination technique - Other non-destructive techniques Global NDT Market, By Application - Flaw detection - Leak detection - Dimensional measurement - Estimation of physical properties - Chemical Composition Determination - Stress & Structure Analysis Global NDT Market, By Geography - G7 Nations - - U.S. - - Canada - - Japan - - Italy - - France - - Germany - - U.K. - BRICS - - Brazil - - Russia - - India - - China - - South Africa - - U.K. - Rest of the World - - South Korea - - Saudi Arabia - - Others Companies Mentioned - Ashtead Technology, Inc - Bosello High Technology S.R.L - Fujifilm Holding Corporation - GE Measurement & Control - Intertek Group PLC. - Mistras Group, Inc. - Nikon Metrology, Inc - Olympus Corporation - SGS SA - Sonatest Ltd For more information visit http://www.researchandmarkets.com/research/g3...estructive
Olympus Releases Statement in Response to US Senate HELP Committee Report
PR Newswire - Wed Jan 13, 9:53AM CST
The Democratic staff of the Senate Committee on Health, Education, Labor and Pensions released today a report that is an important contribution to understanding the factors underlying reports of patient infections associated with multi-drug resistant organisms such as Carbapenem-resistant Enterobacteriaceae following Endoscopic Retrograde Cholangiopancreatography procedures. ERCP is most commonly performed to diagnose and treat conditions in the pancreas, bile duct and gallbladder.
Gloal Capsule Endoscope Systems Strategic Business Report 2015-2020
M2 - Fri Jan 08, 6:10AM CST
Research and Markets (http://www.researchandmarkets.com/research/65czqw/capsule_endoscope) has announced the addition of the "Capsule Endoscope Systems - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Capsule Endoscope Systems in US$. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 14 companies including many key and niche players such as - CapsoVision, Inc. (US) Check-Cap Ltd. (Israel) - Given Imaging Ltd. (Israel) - IntroMedic Co., Ltd. (South Korea) - Chongqing Jinshan Science & Technology (Group) Co., Ltd. (China) - Olympus Corporation (Japan) - RF Co., Ltd. (Japan) Key Topics Covered: 1. MARKET OVERVIEW 2. MARKET DRIVERS, TRENDS & ISSUES 3. COMPETITIVE LANDSCAPE 4. TECHNOLOGICAL DEVELOPMENTS 5. PRODUCT OVERVIEW 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 14 (including Divisions/Subsidiaries - 17) - The United States (5) - Canada (1) - Japan (3) - Europe (3) - - Germany (1) - - The United Kingdom (1) - - Rest of Europe (1) - Asia-Pacific (Excluding Japan) (3) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/65..._endoscope
Minimally Invasive Cardiothoracic, Vascular Surgery, Cosmetic, Urological Surgical Instrument Market 2015-2021
M2 - Thu Dec 17, 9:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/52kzfv/minimally) has announced the addition of the "Minimally invasive surgical instrument market , Products, applications, Trends, forecast 2015-2021" report to their offering. Globally Minimally invasive / non invasive surgery and devices are widely adopted due to increase in surgeries. According to Centers for Disease Control and Prevention, there has been a solid increase in the surgeries in the US. Earlier the surgeries involved with much pain, however, with the introduction of minimally invasive/non invasive surgeries the patient experiences less pain, shorter hospital stay, less complication, quick recovery and less blood loss. Additionally, the minimally invasive surgeries with minimum insertion leave very small scars compared to the traditional surgeries. As a result the adoption of minimally invasive surgeries paced up over the years. The Minimally invasive/non invasive devices and surgical market is growing at an impressive pace with a CAGR of 11% during 2015-2021. The market is segmented on the basis of product and applications. The product includes wide range of devices such as endoscopic devices, handheld devices, guiding devices, inflation systems, surgical robots and so on. By applications the market is segmented in cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, laparoscopic surgery, diagnostics, and cosmetic surgery and so on. Moreover, the report has covered only the product market of global minimally invasive/non invasive surgery instrument and device market. Moreover, increase in healthcare expenditure, increase in life style oriented diseases such as Cancer, CVD, CHD, disability and other heart diseases is also influencing the minimally invasive/non invasive instrument and device market. Major players of minimally invasive/non invasive surgery and device market includes GE Healthcare, Siemens, Stryker, Olympus, Medtronic, Abbott Diagnostics, Toshiba medical systems, Boston scientific, J&J, Aesculap, Intuitive surgical. Key Topics Covered: 1. Introduction 2. Market Overview 3. Market determinants 4. Market Segmentation 5. Market Share and Strategy 6. Geographical Analysis 7. Companies profiled - Abbot Laboratories - Aesculap INC - Biomet Inc - Boston Scientific - Conmed Corporation - Cooper Surgical Inc - Ethicon Endo-Surgery Inc - GE Healthcare - Given Imaging - Hitachi Medical Corporation - Intuitive Surgical - Johnson and Johnson - Karl Storz Endoscope Berlin GMBH - Medtronic - Olympus Corporation - Philips - Siemens - Smith & Nephew PLC - Stryker - Toshiba Medical Systems For more information visit http://www.researchandmarkets.com/research/52kzfv/minimally About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ISRG: 687.55 (+2.26), BSX: 24.30 (+0.33), SNN: 32.88 (-0.12), JNJ: 119.92 (+0.88), MDT: 87.46 (+0.86)
ENT Devices Market by Product, Surgical, & End User - Global Forecast to 2020 for the $14 Billion Industry
M2 - Thu Dec 17, 7:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/3tjb9d/ent_devices) has announced the addition of the "ENT Devices Market by Product, Surgical, & End User - Global Forecast to 2020" report to their offering. The ENT devices market is poised to reach USD 14,001.3 million by 2020 from USD 10,219.3 million in 2015, growing at a CAGR of 6.5% from 2015 to 2020. This market is categorized on the basis of products, end users, and regions. Major factors contributing to the growth of the global ENT devices market include high prevalence of chronic sinusitis, rising geriatric population, favorable reimbursement scenario for ENT procedures in developed countries, rising adoption of minimally invasive ENT procedures, increasing presence of prominent players in the ENT devices market, and technological advancements However, changes in the reimbursement policy for Tracheoesophageal Voice Prosthesis (TEP) devices in the U.S., high cost of CO2 lasers, and high cost and lack of reimbursement for hearing aids are factors that are likely to restrict the growth of this market during the forecast period. North America commands the largest share of the global ENT devices market in 2015 and is expected to grow at a second-highest growth rate from 2015-2020. According to the Centers for Disease Control and Prevention (CDC), in January 2015, in the U.S., about 12.1% of adult population or 28.5 million people are suffering from chronic sinusitis, which is making it more prevalent disease than diabetes and asthma. Also, chronic sinusitis is one of the ten 10 medical conditions which contribute to -USD 8.6 billion of direct healthcare cost in the U.S. Every year, around 500,000 sinus surgeries (operating room) are performed in the U.S. Thus, high prevalence of sinusitis is one of the major factors that will further increase the demand for ENT surgical devices, thereby driving the growth of North American ENT devices market. The report provides insights on the following pointers: - Market Penetration: Comprehensive information on the product portfolios of top players in the ENT devices market. The report analyzes the ENT devices market by product, end user, and region - Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the ENT devices market - Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the ENT devices market - Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for ENT devices across geographies - Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the ENT devices market Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 ENT Devices Market, By Product 7 ENT Devices Market, By End User 8 ENT Devices Market, By Region 9 Competitive Landscape 10 Company Profiles - Acclarent, Inc. (A Subsidiary of Johnson & Johnson) - Cochlear Limited - Hoya Corporation - Karl Storz Gmbh & Co. Kg - Medtronic PLC - Olympus Corporation - Smith & Nephew PLC - Sonova Holding AG - Stryker Corporation - William Demant Holding A/S For more information visit http://www.researchandmarkets.com/research/3t...nt_devices
SNN: 32.88 (-0.12), JNJ: 119.92 (+0.88), MDT: 87.46 (+0.86), SYK: 116.28 (+1.84)
Medtronic-Samsung to Advance Neuromodulation Therapy
Zacks Equity Research - Zacks Investment Research - Mon Dec 14, 1:20PM CST
Through this partnership, Medtronic (MDT) aims to deliver its next-generation neuromodulation therapies with the help of Samsung's smart mobile technology
BABY: 39.44 (+0.74), MASI: 59.65 (+0.68), MDT: 87.46 (+0.86)
Becton, Dickinson Unveils BD FACSCelesta Flow Cytometer
Zacks Equity Research - Zacks Investment Research - Mon Dec 14, 12:20PM CST
Becton, Dickinson (BDX), more commonly known as BD, introduced BD FACSCelesta flow cytometer.
BABY: 39.44 (+0.74), BDX: 177.25 (+1.78), MASI: 59.65 (+0.68)
St. Jude Medical Unveils Positive Data from SUNBURST Study
Zacks Equity Research - Zacks Investment Research - Mon Dec 14, 12:10PM CST
St. Jude Medical (STJ) is expected to gain faster FDA approval for its Burst-technology enabled products, on the back of positive data from the SUNBURST study.
BABY: 39.44 (+0.74), MASI: 59.65 (+0.68), STJ: 78.88 (+0.63)
Correction: Hospital Superbug Outbreak story
By BRIAN MELLEY - AP - Fri Aug 26, 6:40PM CDT
LOS ANGELES (AP) — In a Feb. 20, 2015 story about an antibiotic-resistant "superbug" outbreak at Ronald Reagan UCLA Medical Center, The Associated Press mischaracterized a statement an expert made about proving the cause of an infection. Lawrence Muscarella, a health care and sterilization expert, said he was suggesting an argument hospitals might use when he said, "Proving causation is impossible." Muscarella said an infection can be proven to come from a hospital instrument.
Zacks.com featured highlights: Apogee Enterprises, AMN Healthcare Services, Gibraltar Industries, Liberty Interactive Group and Olympus
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:30AM CDT
Zacks.com featured highlights: Apogee Enterprises, AMN Healthcare Services, Gibraltar Industries, Liberty Interactive Group and Olympus
APOG: 49.02 (+1.05), AHS: 35.85 (+0.08), ROCK: 39.11 (+0.86), QVCA: 21.17 (+0.08)
Look Beyond Earnings: 5 Stocks with Increasing Cash Flows
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:11AM CDT
For any prudent investment, look at a company's ability to produce cash, the lifeblood of business, the fuel for growth and a cushion to downturn.
APOG: 49.02 (+1.05), AHS: 35.85 (+0.08), ROCK: 39.11 (+0.86), QVCA: 21.17 (+0.08)
VIDA and Olympus Expand Strategic Partnership
PR Newswire - Mon May 16, 12:50PM CDT
VIDA Diagnostics, Inc. ("VIDA"
, the leader in precision pulmonary imaging, announced an expanded collaboration with Olympus Respiratory America, a leading developer of devices for the treatment of acute and chronic conditions of the lung and a subsidiary of Olympus Corporation, at the 2016 American Thoracic Society Meeting. Under the agreement, VIDA and Olympus will incorporate precision informatics into current and future diagnostic and therapeutic procedural workflows to manage patients with pulmonary diseases. Olympus Corporation of the Americas Enters Into US And Canada Distribution Agreement With Arc Medical Design Ltd, A Subsidiary Of Norgine For ENDOCUFF VISION®
PR Newswire - Fri May 06, 7:00AM CDT
Olympus Corporation of the Americas today announced a new distribution agreement with Norgine B.V. and its subsidiary Arc Medical Design Ltd. by which Olympus Corporation of the Americas becomes the exclusive distributor of ENDOCUFF VISION® in the U.S. and Canada. The ENDOCUFF VISION® will be showcased at the adjoining Arc and Olympus booths at the Digestive Disease Week (DDW) conference in San Diego, Calif. May 22-26, 2016.
Mitsubishi Motors says false mileage tests done since 1991
By YURI KAGEYAMA - AP - Tue Apr 26, 6:30PM CDT
TOKYO (AP) — Mitsubishi Motors Corp., the Japanese automaker that acknowledged last week that it had intentionally lied about fuel economy data for some models, said an internal investigation found such tampering dated to 1991.
Olympus Corporation Promotes Donna Miller to Head of HQ Legal/Global General Counsel and Caroline West to Global Chief Compliance Officer
PR Newswire - Mon Apr 25, 8:05AM CDT
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced the appointment of two senior level positions in the company. The promotions represent the continued globalization of the Company and reinforce the Company's commitment to an increasingly proactive approach to rapidly changing international markets. These promotions further underscore the importance of the compliance and legal departments in meeting company objectives.
Digital Pathology Market: Global Industry Analysis 2015-2025 - Key Players are GE Healthcare, Sectra AB & Olympus Corporation - Research and Markets
BusinessWire - Mon Apr 18, 7:36AM CDT
Research and Markets has announced the addition of the "Digital Pathology Market: Global Industry Analysis and Opportunity Assessment, 2015-2025" report to their offering.
Report: More infections from dirty scopes than estimated
By MATTHEW PERRONE - AP - Fri Apr 15, 5:00PM CDT
WASHINGTON (AP) — At least 300 patients have been sickened by life-threatening infections linked to contaminated medical scopes — more than previously estimated by federal regulators, according to figures released Friday.
Global Life Science Microscopy Devices Market Assessments & Forecasts 2015-2019 with Leica Microsystems, Olympus, JEOL, Carl Zeiss, FEI, Meiji Techno & Tescan Orsay
GlobeNewswire - Fri Jan 29, 2:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/55pccb/global_life) has announced the addition of the "Global Life Science Microscopy Devices Market Assessment & Forecast: 2015 - 2019" report to their offering.
Cell Analysis Market Forecast to 2020 - Expected to Reach $26 Billion, Growing at CAGR of 6.56%
M2 - Mon Jan 25, 3:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/mxg28x/cell_analysis) has announced the addition of the "Cell Analysis Market by Product, & Consumables, by Process, & by End User - Forecast to 2020" report to their offering. The global cell analysis market is expected to reach $26.0 billion by 2020 from $19.0 billion in 2015, growing at a CAGR of 6.56% from 2015 to 2020. The instruments segment is expected to register the highest growth rate in the cell analysis market, by product, during the forecast period. Its favorable growth is attributed to biological relevance for new drug discoveries, cancer research, and government funding & support for cell-based research. Furthermore, instruments are rapidly adopted by biotechnology and biopharmaceutical industries for performing cell analysis biotechnology products and biopharmaceuticals. This is another major reason for the growth of this market. Major factors contributing to growth of the cell analysis market include: - Rising incidence of chronic and infectious diseases - Growing healthcare industry and medical spending - Rising incidence of cancer - Introduction of technologically advanced products - Corporate and government funding for cell-based research. The relatively untapped markets of the Asia-Pacific region and the advent of microfluidics in cell analysis have opened an array of opportunities for the cell analysis market. However, reluctance amongst researchers to use advanced cell analysis techniques and high cost of instruments are expected to restrain the growth of this market. Companies Mentioned: - Agilent Technologies, Inc. - Becton, Dickinson and Company - Danaher Corporation - GE Healthcare - Merck KGAA - Olympus Corporation - Perkinelmer, Inc. - Promega Corporation - Tecan Group Ltd. - Thermo Fisher Scientific, Inc. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Global Cell Analysis Market, By Product 7 Global Cell Analysis Market, By Process 8 Global Cell Analysis Market, By End User 9 Global Cell Analysis Market, By Region 10 Competitive Landscape 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/mx...l_analysis
A: 47.62 (+0.30), DHR: 82.13 (+0.29)
Global Life Science Microscopy Devices Market - Expected to Grow to $2,472.2 Million by 2019 at a CAGR of 6.8%
M2 - Fri Jan 22, 3:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/gl3kg6/global_life) has announced the addition of the "Global Life Science Microscopy Devices Market Assessment & Forecast: 2015 - 2019" report to their offering. Pricing remains a major challenge to growth of the market as potential buyers still continue to rely on refurbished sales. Spares and additional parts of several high-resolution microscopes are considerably expensive. Moreover several microscopes use radiation for which shielding is of extreme importance. Thus a large variety of modern microscopy technology continues to be out of reach for most academic and research organizations in emerging countries. In well-funded institutions within emerging countries such as India, Malaysia, Brazil, China students and researchers are required to accommodate with using just one or two systems. Since the average cost of scanning probe and electron microscopes can exceed beyond US$ 500,000 - US$ 2,000,000 the cost accounts for a sizable portion of the total funds allotted. Although economy in these regions is improving, their purchase power is expected to be strong only by the end of the forecast period or may even extend into the next decade. Companies Mentioned: - Accu Scope Inc - Bruker Corporation - Carl Zeiss GmbH - Coxem - Etaluma - Euromex Microscopes - FEI Company - Hitachi Hightech - Horiba Ltd - JEOL Ltd - Meiji Techno - Nikon Corporation - Olympus Corporation - Optika Italy - Park Systems - Renishaw - Rigaku Corporation - Tescan Orsay Holdings - TSI - Variscope Key Topics Covered: Chapter 1 Preface Chapter 2 Market Inferences Chapter 3 Market Dynamics Chapter 4 Life Science Microscopy Devices - By Technology Chapter 5 Life Science Microscopy Devices - By Applications Chapter 6 Life Science Microscopy Devices - By Geography For more information visit http://www.researchandmarkets.com/research/gl...lobal_life
FEIC: 106.52 (-0.16)
Non Destructive Testing (NDT) Market 2015-2020 by Method (UT, RT, LPT, MPT, ECT, VI), End-User (Aerospace & Defense, Power Generation, Infrastructure, Oil & Gas, Automotive), Technique & Application
M2 - Thu Jan 14, 6:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/g3lm6v/non_destructive) has announced the addition of the "Non Destructive Testing (NDT) Market - Global Forecast to 2020" report to their offering. The non-destructive testing market is estimated to be valued at USD 12.98 Billion in 2015 and is projected to reach USD 18.88 Billion by 2020, at a CAGR of 7.78% from 2015 to 2020. This report provides qualitative and quantitative information about the global NDT market. It identifies the market application gaps, emerging technologies, the need for new product launches, and high potential geographic regions and countries. It also provides a segmentation of the market, tracking the market size, market share, revenue projections, and financial portfolio, covering a broad spectrum of the different methods, end-user, applications, and techniques of NDT industry. NDT is considered a basic need in industries such as aerospace, oil & gas, petroleum, and construction, among others. Innovations in the NDT equipment market have increased commercially after the introduction of advanced X-ray equipment such as micro focus X-ray tools, integrated X-ray equipment, glass X-ray tubes with window, radiation shielded X-ray equipment, and so on. Furthermore, the forecast period offers huge growth potential for technologies such as computed tomography, phased array ultrasonic testing, and data management tools as these techniques are more efficient in terms of deriving accurate results. The research methodology used to estimate and forecast the NDT market begins with capturing data on key NDT equipment revenues through secondary research. The NDT service offerings are also taken into consideration to determine the market segmentation. The bottom-up procedure was employed to arrive at the overall market size of the global NDT market from the revenue of the key players in the market. After arriving at the overall market size, the total market was split into several segments and sub-segments which are then verified through primary research by conducting extensive interviews with key people such as CEOs, VPs, Directors and executives. This data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments. The ecosystem of the NDT market comprises oil exploration industry, oil refineries, aerospace industry, construction industry, inspection service providers, and non-destructive testing facilities among other. This report would help the NDT component supplier, NDT service providers, safety and regulatory authorities to identify hot revenue pockets in this market. Scope of the Report This research report categorizes the NDT market into the following segments and sub-segments: Global NDT Market, By Method - Ultrasonic testing - Radiography testing - Liquid Penetrant testing - Magnetic particle testing - Eddy-current testing - Visual inspection Global NDT Market, By End-User - Aerospace & Defense industry - Automotive industry - Oil & gas industry - Infrastructure Industry - Power generation industry Global NDT Market, By Technique - Surface Examination technique - Volumetric Examination Technique - Condition Monitoring technique - Integrity Examination technique - Other non-destructive techniques Global NDT Market, By Application - Flaw detection - Leak detection - Dimensional measurement - Estimation of physical properties - Chemical Composition Determination - Stress & Structure Analysis Global NDT Market, By Geography - G7 Nations - - U.S. - - Canada - - Japan - - Italy - - France - - Germany - - U.K. - BRICS - - Brazil - - Russia - - India - - China - - South Africa - - U.K. - Rest of the World - - South Korea - - Saudi Arabia - - Others Companies Mentioned - Ashtead Technology, Inc - Bosello High Technology S.R.L - Fujifilm Holding Corporation - GE Measurement & Control - Intertek Group PLC. - Mistras Group, Inc. - Nikon Metrology, Inc - Olympus Corporation - SGS SA - Sonatest Ltd For more information visit http://www.researchandmarkets.com/research/g3...estructive
Olympus Releases Statement in Response to US Senate HELP Committee Report
PR Newswire - Wed Jan 13, 9:53AM CST
The Democratic staff of the Senate Committee on Health, Education, Labor and Pensions released today a report that is an important contribution to understanding the factors underlying reports of patient infections associated with multi-drug resistant organisms such as Carbapenem-resistant Enterobacteriaceae following Endoscopic Retrograde Cholangiopancreatography procedures. ERCP is most commonly performed to diagnose and treat conditions in the pancreas, bile duct and gallbladder.
Gloal Capsule Endoscope Systems Strategic Business Report 2015-2020
M2 - Fri Jan 08, 6:10AM CST
Research and Markets (http://www.researchandmarkets.com/research/65czqw/capsule_endoscope) has announced the addition of the "Capsule Endoscope Systems - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Capsule Endoscope Systems in US$. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 14 companies including many key and niche players such as - CapsoVision, Inc. (US) Check-Cap Ltd. (Israel) - Given Imaging Ltd. (Israel) - IntroMedic Co., Ltd. (South Korea) - Chongqing Jinshan Science & Technology (Group) Co., Ltd. (China) - Olympus Corporation (Japan) - RF Co., Ltd. (Japan) Key Topics Covered: 1. MARKET OVERVIEW 2. MARKET DRIVERS, TRENDS & ISSUES 3. COMPETITIVE LANDSCAPE 4. TECHNOLOGICAL DEVELOPMENTS 5. PRODUCT OVERVIEW 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 14 (including Divisions/Subsidiaries - 17) - The United States (5) - Canada (1) - Japan (3) - Europe (3) - - Germany (1) - - The United Kingdom (1) - - Rest of Europe (1) - Asia-Pacific (Excluding Japan) (3) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/65..._endoscope
Minimally Invasive Cardiothoracic, Vascular Surgery, Cosmetic, Urological Surgical Instrument Market 2015-2021
M2 - Thu Dec 17, 9:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/52kzfv/minimally) has announced the addition of the "Minimally invasive surgical instrument market , Products, applications, Trends, forecast 2015-2021" report to their offering. Globally Minimally invasive / non invasive surgery and devices are widely adopted due to increase in surgeries. According to Centers for Disease Control and Prevention, there has been a solid increase in the surgeries in the US. Earlier the surgeries involved with much pain, however, with the introduction of minimally invasive/non invasive surgeries the patient experiences less pain, shorter hospital stay, less complication, quick recovery and less blood loss. Additionally, the minimally invasive surgeries with minimum insertion leave very small scars compared to the traditional surgeries. As a result the adoption of minimally invasive surgeries paced up over the years. The Minimally invasive/non invasive devices and surgical market is growing at an impressive pace with a CAGR of 11% during 2015-2021. The market is segmented on the basis of product and applications. The product includes wide range of devices such as endoscopic devices, handheld devices, guiding devices, inflation systems, surgical robots and so on. By applications the market is segmented in cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, laparoscopic surgery, diagnostics, and cosmetic surgery and so on. Moreover, the report has covered only the product market of global minimally invasive/non invasive surgery instrument and device market. Moreover, increase in healthcare expenditure, increase in life style oriented diseases such as Cancer, CVD, CHD, disability and other heart diseases is also influencing the minimally invasive/non invasive instrument and device market. Major players of minimally invasive/non invasive surgery and device market includes GE Healthcare, Siemens, Stryker, Olympus, Medtronic, Abbott Diagnostics, Toshiba medical systems, Boston scientific, J&J, Aesculap, Intuitive surgical. Key Topics Covered: 1. Introduction 2. Market Overview 3. Market determinants 4. Market Segmentation 5. Market Share and Strategy 6. Geographical Analysis 7. Companies profiled - Abbot Laboratories - Aesculap INC - Biomet Inc - Boston Scientific - Conmed Corporation - Cooper Surgical Inc - Ethicon Endo-Surgery Inc - GE Healthcare - Given Imaging - Hitachi Medical Corporation - Intuitive Surgical - Johnson and Johnson - Karl Storz Endoscope Berlin GMBH - Medtronic - Olympus Corporation - Philips - Siemens - Smith & Nephew PLC - Stryker - Toshiba Medical Systems For more information visit http://www.researchandmarkets.com/research/52kzfv/minimally About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ISRG: 687.55 (+2.26), BSX: 24.30 (+0.33), SNN: 32.88 (-0.12), JNJ: 119.92 (+0.88), MDT: 87.46 (+0.86)
ENT Devices Market by Product, Surgical, & End User - Global Forecast to 2020 for the $14 Billion Industry
M2 - Thu Dec 17, 7:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/3tjb9d/ent_devices) has announced the addition of the "ENT Devices Market by Product, Surgical, & End User - Global Forecast to 2020" report to their offering. The ENT devices market is poised to reach USD 14,001.3 million by 2020 from USD 10,219.3 million in 2015, growing at a CAGR of 6.5% from 2015 to 2020. This market is categorized on the basis of products, end users, and regions. Major factors contributing to the growth of the global ENT devices market include high prevalence of chronic sinusitis, rising geriatric population, favorable reimbursement scenario for ENT procedures in developed countries, rising adoption of minimally invasive ENT procedures, increasing presence of prominent players in the ENT devices market, and technological advancements However, changes in the reimbursement policy for Tracheoesophageal Voice Prosthesis (TEP) devices in the U.S., high cost of CO2 lasers, and high cost and lack of reimbursement for hearing aids are factors that are likely to restrict the growth of this market during the forecast period. North America commands the largest share of the global ENT devices market in 2015 and is expected to grow at a second-highest growth rate from 2015-2020. According to the Centers for Disease Control and Prevention (CDC), in January 2015, in the U.S., about 12.1% of adult population or 28.5 million people are suffering from chronic sinusitis, which is making it more prevalent disease than diabetes and asthma. Also, chronic sinusitis is one of the ten 10 medical conditions which contribute to -USD 8.6 billion of direct healthcare cost in the U.S. Every year, around 500,000 sinus surgeries (operating room) are performed in the U.S. Thus, high prevalence of sinusitis is one of the major factors that will further increase the demand for ENT surgical devices, thereby driving the growth of North American ENT devices market. The report provides insights on the following pointers: - Market Penetration: Comprehensive information on the product portfolios of top players in the ENT devices market. The report analyzes the ENT devices market by product, end user, and region - Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the ENT devices market - Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the ENT devices market - Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for ENT devices across geographies - Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the ENT devices market Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 ENT Devices Market, By Product 7 ENT Devices Market, By End User 8 ENT Devices Market, By Region 9 Competitive Landscape 10 Company Profiles - Acclarent, Inc. (A Subsidiary of Johnson & Johnson) - Cochlear Limited - Hoya Corporation - Karl Storz Gmbh & Co. Kg - Medtronic PLC - Olympus Corporation - Smith & Nephew PLC - Sonova Holding AG - Stryker Corporation - William Demant Holding A/S For more information visit http://www.researchandmarkets.com/research/3t...nt_devices
SNN: 32.88 (-0.12), JNJ: 119.92 (+0.88), MDT: 87.46 (+0.86), SYK: 116.28 (+1.84)
Medtronic-Samsung to Advance Neuromodulation Therapy
Zacks Equity Research - Zacks Investment Research - Mon Dec 14, 1:20PM CST
Through this partnership, Medtronic (MDT) aims to deliver its next-generation neuromodulation therapies with the help of Samsung's smart mobile technology
BABY: 39.44 (+0.74), MASI: 59.65 (+0.68), MDT: 87.46 (+0.86)
Becton, Dickinson Unveils BD FACSCelesta Flow Cytometer
Zacks Equity Research - Zacks Investment Research - Mon Dec 14, 12:20PM CST
Becton, Dickinson (BDX), more commonly known as BD, introduced BD FACSCelesta flow cytometer.
BABY: 39.44 (+0.74), BDX: 177.25 (+1.78), MASI: 59.65 (+0.68)
St. Jude Medical Unveils Positive Data from SUNBURST Study
Zacks Equity Research - Zacks Investment Research - Mon Dec 14, 12:10PM CST
St. Jude Medical (STJ) is expected to gain faster FDA approval for its Burst-technology enabled products, on the back of positive data from the SUNBURST study.
BABY: 39.44 (+0.74), MASI: 59.65 (+0.68), STJ: 78.88 (+0.63)
